AU779846B2 - Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins - Google Patents

Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins Download PDF

Info

Publication number
AU779846B2
AU779846B2 AU79972/00A AU7997200A AU779846B2 AU 779846 B2 AU779846 B2 AU 779846B2 AU 79972/00 A AU79972/00 A AU 79972/00A AU 7997200 A AU7997200 A AU 7997200A AU 779846 B2 AU779846 B2 AU 779846B2
Authority
AU
Australia
Prior art keywords
gly
ala
ral2
polypeptide
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU79972/00A
Other languages
English (en)
Other versions
AU7997200A (en
Inventor
Jeffrey Guderian
Yasir Skeiky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU7997200A publication Critical patent/AU7997200A/en
Application granted granted Critical
Publication of AU779846B2 publication Critical patent/AU779846B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU79972/00A 1999-10-07 2000-10-06 Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins Ceased AU779846B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15858599P 1999-10-07 1999-10-07
US60/158585 1999-10-07
PCT/US2000/027652 WO2001025401A2 (en) 1999-10-07 2000-10-06 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins

Publications (2)

Publication Number Publication Date
AU7997200A AU7997200A (en) 2001-05-10
AU779846B2 true AU779846B2 (en) 2005-02-17

Family

ID=22568818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79972/00A Ceased AU779846B2 (en) 1999-10-07 2000-10-06 Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins

Country Status (12)

Country Link
US (1) US20060040356A1 (enExample)
EP (1) EP1517913B9 (enExample)
JP (1) JP2003527830A (enExample)
AT (1) ATE354663T1 (enExample)
AU (1) AU779846B2 (enExample)
CA (1) CA2386854A1 (enExample)
CY (1) CY1106593T1 (enExample)
DE (1) DE60033583T2 (enExample)
DK (1) DK1517913T3 (enExample)
ES (1) ES2282142T3 (enExample)
PT (1) PT1517913E (enExample)
WO (1) WO2001025401A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2133100E (pt) * 2000-06-20 2012-01-11 Corixa Corp Antigénio mtb32a de mycobacterium tuberculosis com um local activo inactivado e suas proteínas de fusão
BRPI0518933A2 (pt) 2004-11-16 2008-12-16 Crucell Holland B V E Aeras Gl adenovÍrus recombinante defeituoso de replicaÇço, vetor de polinucleotÍdeo recombinante, vacina multivalente da tuberculose, e, uso do antÍgeno tb10.4 de mycobacterium
CN104292089B (zh) * 2014-09-30 2016-01-13 大连九信生物化工科技有限公司 一种1-氯-1’-氯乙酰基环丙烷的合成工艺

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009429A2 (en) * 1995-09-01 1997-03-13 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
WO1999042076A2 (en) * 1998-02-18 1999-08-26 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1999051748A2 (en) * 1998-04-07 1999-10-14 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566072B1 (en) * 1995-05-31 2003-05-20 Washington University Mammaglobin, a secreted mammary-specific breast cancer protein
US6458366B1 (en) * 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
EP0925364B1 (en) * 1996-09-06 2002-10-23 Bioteknologisk Institut A lactic acid bacterial regulatable expression system
CA2268036A1 (en) * 1996-10-11 1998-04-23 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6350456B1 (en) * 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6627198B2 (en) * 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
FR2767337B1 (fr) * 1997-08-14 2002-07-05 Pasteur Institut Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
AU741130B2 (en) * 1997-09-16 2001-11-22 Oregon Health Sciences University Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
US6448234B1 (en) * 1998-12-08 2002-09-10 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6509448B2 (en) * 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7009042B1 (en) * 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
EP1229931A4 (en) * 1999-10-07 2003-05-28 Corixa Corp FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS
AU1656501A (en) * 1999-11-12 2001-06-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
EP1261708A2 (en) * 2000-01-14 2002-12-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2001073032A2 (en) * 2000-03-27 2001-10-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
PT2133100E (pt) * 2000-06-20 2012-01-11 Corixa Corp Antigénio mtb32a de mycobacterium tuberculosis com um local activo inactivado e suas proteínas de fusão

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009429A2 (en) * 1995-09-01 1997-03-13 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
WO1999042076A2 (en) * 1998-02-18 1999-08-26 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1999051748A2 (en) * 1998-04-07 1999-10-14 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses

Also Published As

Publication number Publication date
EP1517913A2 (en) 2005-03-30
AU7997200A (en) 2001-05-10
ES2282142T3 (es) 2007-10-16
DE60033583T2 (de) 2007-09-13
WO2001025401A2 (en) 2001-04-12
CA2386854A1 (en) 2001-04-12
JP2003527830A (ja) 2003-09-24
CY1106593T1 (el) 2012-01-25
DE60033583D1 (de) 2007-04-05
ATE354663T1 (de) 2007-03-15
EP1517913B1 (en) 2007-02-21
EP1517913A4 (en) 2005-09-14
EP1517913B9 (en) 2007-08-29
WO2001025401A3 (en) 2005-02-03
PT1517913E (pt) 2007-05-31
US20060040356A1 (en) 2006-02-23
DK1517913T3 (da) 2007-06-18
WO2001025401A9 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
CA2326598C (en) Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6913907B2 (en) Enterococcus faecalis polynucleotides encoding EF059
EP0722461B1 (en) Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
CN101107361B (zh) 二硫桥连双链形式的蛋白质的重组表达
JP4940479B2 (ja) マイコバクテリウム・ツベルクローシス融合蛋白質及びその応用
CA2894951A1 (en) Immunogenic composition comprising elements of c. difficile cdtb and/or cdta proteins
CA2294568A1 (en) Lyme disease vaccines
CA2405247A1 (en) Tuberculosis antigens and methods of use thereof
KR20220069018A (ko) 재조합 인터류킨-15 유사체
US7009042B1 (en) Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
EP2397555A1 (en) Fusion proteins of mycobacterium tuberculosis antigens and their uses
JP3316535B2 (ja) ダニアレルゲンの改変体およびその製造法
EP1517913B9 (en) A mycobacterium tuberculosis coding sequence for exression of heterologous proteins
AU696349B2 (en) Methods for peptide synthesis and purification
CA2239704A1 (en) Polypeptides with interleukin 16 activity, process for the preparation and use thereof
US20030027774A1 (en) Tuberculosis antigens and methods of use therefor
WO2007118077A2 (en) Mycobacterial catalase-peroxidase in the diagnosis and treatment of sarcoidosis
AU2004257206A1 (en) Recombinant expression of Streptococcus pyogenes cysteine protease and immunogenic compositions thereof
EP0889899A1 (en) Mycoplasma arthritidis superantigen
EP2083016B1 (en) Bacterial superantigen vaccines
CA2253259A1 (en) Processed polypeptides with il-16 activity, process for preparing the same and their use
JP2001231580A (ja) マウンテンシダー花粉アレルゲンタンパク質及び該タンパク質をコードする核酸分子
JP2003174886A (ja) 新規タンパク質およびそのｄｎａ